Atrial Fibrillation During Zanubrutinib Treatment in Chronic Lymphocytic Leukemia With a Historical Ibrutinib Control
eJHaem · 2026-12 · 7 (6)
DOI: 10.1002/jha2.70451 ↗Kurz gefasst
Fachartikel in der Zeitschrift eJHaem, online erschienen am 14.11.2026. Verfasst von Andrea Visentin und 59 weiteren Autor:innen. Beteiligte Einrichtung: Hematology Unit Department of Medicine-DIMED University of Padova Padova Italy. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Atrial fibrillation (AF) complicates Bruton tyrosine kinase inhibitor therapy in chronic lymphocytic leukemia.
Methods
We retrospectively evaluated 679 zanubrutinib‐treated patients across 52 Italian centers, with 354 historical ibrutinib‐treated controls. Shanafelt AF scores were assessed.
Results
Nine zanubrutinib‐treated patients developed AF (1.33%) during median treatment of 15.5 months, versus 42 historical controls (11.9%) over median observation of 25 months. Five zanubrutinib events occurred among patients scoring ≥ 5. No affected patients experienced embolic or bleeding complications.
Conclusion
AF was uncommon during zanubrutinib treatment, even in the higher‐risk subgroup. Historical comparisons remain limited, and exploratory score findings require confirmation with longer follow‐up. Trial Registration The authors have confirmed clinical trial registration is not needed for this submission
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Hematology Unit Department of Medicine-DIMED University of Padova Padova Italy.
- Hematology Unit Department of Onco-Hematology Azienda Ospedaliera Annunziata Cosenza Italy.
- Institute of Clinical Physiology (IFC-CNR) Rome Italy.
- Hematology and Stem Cell Transplantation Unit A.O.U.Policlinico G. Rodolico - San Marco Catania Italy.
- SOC Clinica Ematologia Azienda Sanitaria Universitaria Friuli Centrale (ASU FC) Udine Italy.
- Department of Engineering for Innovation Medicine University of Verona Verona Italy.
Zitieren
APA
Visentin, A., Martino, E. A., Cellini, A., Angotzi, F., Pitino, A., Duminuco, A., Vigna, E., Pasquale, R., Ferrarini, I., Moia, R., Sanna, A., Motta, M., Moratti, M., Sportoletti, P., Chiarenza, A., Maggi, A., Zammit, V., Merli, M., Innocenti, I., …, & Morello, L. (2026). Atrial Fibrillation During Zanubrutinib Treatment in Chronic Lymphocytic Leukemia With a Historical Ibrutinib Control. eJHaem, 7(6). https://doi.org/10.1002/jha2.70451
Vancouver
Visentin A, Martino EA, Cellini A, Angotzi F, Pitino A, Duminuco A, et al. Atrial Fibrillation During Zanubrutinib Treatment in Chronic Lymphocytic Leukemia With a Historical Ibrutinib Control. eJHaem. 2026;7(6). doi:10.1002/jha2.70451
BibTeX
@article{Visentin2026,
author = {Visentin, Andrea and Martino, Enrica Antonia and Cellini, Alessandro and Angotzi, Francesco and Pitino, Annalisa and Duminuco, Andrea and Vigna, Ernesto and Pasquale, Raffaella and Ferrarini, Isacco and Moia, Riccardo and Sanna, Alessandro and Motta, Marina and Moratti, Massimo and Sportoletti, Paolo and Chiarenza, Annalisa and Maggi, Alessandro and Zammit, Valentina and Merli, Michele and Innocenti, Idanna and Giordano, Claudia and Nocilli, Laura and Postorino, Massimiliano and Stelitano, Caterina and Ferrario, Andrea and Frustaci, Anna Maria and Riva, Marcello and Pepe, Sara and Ibatici, Adalberto and Scardino, Stefania and Borza, Paola Anticoli and Ballotta, Laura and Mancuso, Salvatrice and Malaspina, Francesco and Mele, Anna and Galimberti, Sara and Catania, Gioacchino and Giordano, Annamaria and Angeletti, Ilaria and Schiattone, Luana and Pennese, Elsa and Miccolis, Rosanna and Fama, Angelo and Giordano, Giulio and Califano, Catello and Bruzzese, Antonella and Farina, Giuliana and Bulian, Pietro and Loseto, Giacomo and Pocali, Barbara and Innao, Vanessa and Galieni, Piero and Fraticelli, Vincenzo and Vitale, Candida and Romeo, Azzurra and Rossi, Marco and Scortechini, Ilaria and Vozella, Federico and Malandruccolo, Luigi and Varettoni, Marzia and Morello, Lucia},
title = {Atrial Fibrillation During Zanubrutinib Treatment in Chronic Lymphocytic Leukemia With a Historical Ibrutinib Control},
journal = {eJHaem},
year = {2026},
volume = {7},
number = {6},
doi = {10.1002/jha2.70451}
}
EUVIMED